Evidence map›Paper›PMID 34803098›Full record

ArticleInternal medicine (Tokyo, Japan)2022

Successful Treatment of Nephrotic Syndrome Due to Collapsing Focal Segmental Glomerulosclerosis Accompanied by Acute Interstitial Nephritis.

Hisato Shima, Toshio Doi, Takuya Okamoto, Yusuke Higashiguchi, Megumi Harada, Tomoko Inoue, Manabu Tashiro, Seiichiro Wariishi, Norimichi Takamatsu, Kazuhiko Kawahara and 2 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Hisato ShimaDepartment of Kidney Disease, Kawashima Hospital, Japan.
Toshio DoiDepartment of Kidney Disease, Kawashima Hospital, Japan.
Takuya OkamotoDepartment of Laboratory, Kawashima Hospital, Japan.
Yusuke HigashiguchiDepartment of Clinical Engineering Kawashima Hospital, Japan.
Megumi HaradaDepartment of Clinical Engineering Kawashima Hospital, Japan.
Tomoko InoueDepartment of Kidney Disease, Kawashima Hospital, Japan.
Manabu TashiroDepartment of Kidney Disease, Kawashima Hospital, Japan.
Seiichiro WariishiDepartment of Cardiovascular Surgery, Kawashima Hospital, Japan.
Norimichi TakamatsuDepartment of Laboratory, Kawashima Hospital, Japan.
Kazuhiko KawaharaDepartment of Kidney Disease, Kawashima Hospital, Japan.
Kazuyoshi OkadaDepartment of Kidney Disease, Kawashima Hospital, Japan.
Jun MinakuchiDepartment of Kidney Disease, Kawashima Hospital, Japan.
Miwa Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 39-year-old woman was hospitalized for nephrotic syndrome. Laboratory test results showed increased serum creatinine levels and urinary excretions of beta-2-microglobulin, and N-acetyl-beta-D-glucosaminidase. A renal biopsy revealed collapsing focal segmental glomerulosclerosis (FSGS) and acute interstitial nephritis. Despite treatment with pulse steroid followed by oral high-dose glucocorticoids and cyclosporines, heavy proteinuria persisted. After low-density lipoprotein apheresis (LDL-A) therapy was initiated, her proteinuria gradually decreased, leading to complete remission. A repeat renal biopsy after treatment revealed no collapsing glomeruli. Immediate LDL-A should be performed to treat cases of collapsing FSGS poorly responding to other treatments.

Indexed as

Glomerulosclerosis, Focal SegmentalNephritis, InterstitialNephrotic SyndromeAdultFemaleHumansKidney GlomerulusProteinuriacollapsing focal segmental glomerulosclerosiscyclosporinlow-density lipoprotein apheresisnephrotic syndromesteroid

Identifiers

PMID34803098
PMCPMC9259812
OpenAlexW3217808776

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.